Patent · US Active

Methods of diagnosing and treating cancer

US10725042B2 · kind B2 · utility

0Cited by
0References
13Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 22, 2013
Grant dateJul 28, 2020
Priority date
Expiry dateSep 14, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of determining the susceptibility of a cancer in a subject to treatment with an antimetabolite includes obtaining a sample of cancer cells from the subject, measuring the level of UDG expression in the cancer cells, and comparing the measured levels of UDG expression in the cancer cells to a control level.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.